Braden Parker
Patrimonio netto: 407 899 $ in data 31/08/2026
Patrimonio netto: 407 899 $ in data 31/08/2026
Braden Parker is Chief Commercial Officer at Savara, Inc. since 2024.
Formerly, Mr. Parker was Chief Commercial Officer at Orchard Therapeutics Plc from 2021 to 2024 and Vice President & General Manager at PTC Therapeutics, Inc. from 2017 to 2020.
Education includes undergraduate studies at the University of Notre Dame and an MBA from The Leonard N Stern School of Business.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
SAVARA, INC. 0,04% | 24/09/2026 | 75.677 ( 0,04% ) | 407 899 $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| SAVARA INC. | Corporate Officer/Principal | 24/09/2024 |
| Società | Posizione | Fine |
|---|---|---|
| ORCHARD THERAPEUTICS PLC | Corporate Officer/Principal | 01/02/2024 |
| PTC THERAPEUTICS, INC. | Corporate Officer/Principal | 01/03/2020 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
PTC Therapeutics, Inc.
PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
University of Notre Dame
University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Leonard N Stern School of Business
The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Savara, Inc.
Savara, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals to treat respiratory diseases | Health Technology |
Orchard Therapeutics Plc
Orchard Therapeutics Plc BiotechnologyHealth Technology Engages in research and advancements of gene therapy to develop potential cures for genetic & other severe diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale